ABOUT STORIES PRODUCTS CERTIFICATIONS RESEARCH AND DEVELOPMENT NEWS & EVENTS CONTACTS Laboratori Derivati Organici (LDO) was acquired entirely by Opocrin Spa, a company that has been involved in the research, production and marketing of active ingredients for the pharmaceutical industry since 1964. The entry into Opocrin places the new Group among the main producers of heparin and derivatives globally, with more than 270 employees. PRESS RELEASE Our Products Heparin Calcic Heparin Heparin Sodium Chondroitin Sulphate Heparin Sulodexide Heparin Heparan Sulfate Stories November 2016: AIFA issues the GMP authorization for the new production plant. READ 40 years of experience in the production of Sodium Heparin READ News & Events November 5, 2019 CPHI FRANKFURT 2019 The LDO team is present at CPhI 2019 in Frankfurt 5-7 November 2019 SHOW ARTICLE 21 October 2016 LDO PARTICIPATES IN THE MATPI WORKSHOP LDO participates with presentation at the workshop “Modern analytical techniques in Pharmaceutical Indust SHOW ARTICLE 4th October 2016 LDO IS PRESENT AT THE CPHI LDO è presente al CPhI “Convention on Pharmaceutical Ingredients” 2016 a Barcellona. MOSTRA ARTICOLO SEDE OPERATIVA LDO S.p.a. Laboratori Derivati Organici Strada Provinciale 31 Bis 13039 Trino (Vercelli) Italy Tel +39 0161 80.20.30 Fax +39 0161 82.86.92 info@opocrin.it SEDE LEGALE LDO S.p.a Laboratori Derivati Organici Strada Scaglia Est n. 5 41126 Modena (MO) Italy Tel +39 05 95.58.352 Fax +39 0592 92.75.70 info@opocrin.it LDO SpA - Organic Derivatives Laboratories - Via Michele Barozzi, 4 - 20122 Milan (MI) Italy - Tel +39 02 76.00.50.21 Fax +39 02 78.49.81 Cod. Fisc./P. VAT 00818110157 - Business Register of Milan n. 00818110157 - REA n. MI-820289 - Share capital 546,000 Euros int. vers. PRIVACY POLICY - COOKIE This site uses third-party technical and statistical analysis cookies. For more information on cookies see our table . To continue browsing you can consent to the use of analytical cookies or deny consent.OkNo